The latest closing stock price for Cyclerion Therapeutics as of November 20, 2024 is 2.09.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-993 today, roughly -1 times their original investment - a -56.05% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 369.20 on April 10, 2019.
The Cyclerion Therapeutics 52-week high stock price is 5.25, which is 151.2% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.71, which is 18.2% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.93.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-993 today, roughly -1 times their original investment - a -56.05% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 369.20 on April 10, 2019.
The Cyclerion Therapeutics 52-week high stock price is 5.25, which is 151.2% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.71, which is 18.2% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.93.